- Home
- XXII vs HSDT Comparison
XXII vs HSDT Comparison
Compare XXII & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- HSDT
- Stock Information
- Founded
- XXII 1998
- HSDT 2014
- Country
- XXII United States
- HSDT United States
- Employees
- XXII N/A
- HSDT N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XXII Health Care
- HSDT Health Care
- Exchange
- XXII Nasdaq
- HSDT Nasdaq
- Market Cap
- XXII 2.1M
- HSDT 1.7M
- IPO Year
- XXII N/A
- HSDT N/A
- Fundamental
- Price
- XXII $0.80
- HSDT $0.29
- Analyst Decision
- XXII
- HSDT Hold
- Analyst Count
- XXII 0
- HSDT 1
- Target Price
- XXII N/A
- HSDT N/A
- AVG Volume (30 Days)
- XXII 1.6M
- HSDT 79.0K
- Earning Date
- XXII 05-14-2025
- HSDT 05-12-2025
- Dividend Yield
- XXII N/A
- HSDT N/A
- EPS Growth
- XXII N/A
- HSDT N/A
- EPS
- XXII N/A
- HSDT N/A
- Revenue
- XXII $24,382,000.00
- HSDT $520,000.00
- Revenue This Year
- XXII $19.23
- HSDT $0.04
- Revenue Next Year
- XXII $81.05
- HSDT $75.10
- P/E Ratio
- XXII N/A
- HSDT N/A
- Revenue Growth
- XXII N/A
- HSDT N/A
- 52 Week Low
- XXII $0.70
- HSDT $0.26
- 52 Week High
- XXII $265.95
- HSDT $4.69
- Technical
- Relative Strength Index (RSI)
- XXII 26.33
- HSDT 35.85
- Support Level
- XXII $0.70
- HSDT $0.26
- Resistance Level
- XXII $0.83
- HSDT $0.30
- Average True Range (ATR)
- XXII 0.21
- HSDT 0.03
- MACD
- XXII 0.05
- HSDT 0.00
- Stochastic Oscillator
- XXII 5.92
- HSDT 30.48
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.